Prophylix Pharma A/S

Forskningsparken
1902 Tromsø
Norway

Contact

About Prophylix Pharma

Prophylix Pharma AS is a Norwegian company founded in 2008 by a group of scientists, Norinnova Technology Transfer AS and University Hospital of Northern Norway in Tromsø . The company is dedicated to develop a new prophylactic treatment of Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT).

Read more about Prophylix Pharma

Revolutionize your production: real-time Raman analysis for maximum efficiency

Efficient inline analysis for liquids and solids

User-friendly software for effortless Design of Experiments (DoE)

News about Prophylix Pharma

09-May-2012 | business & finance

Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding

The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia

Read news

Show more news about Prophylix Pharma

Get the life science industry in your inbox

Prophylix Pharma A/S

About Prophylix Pharma

News about Prophylix Pharma

Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding

Here you will find Prophylix Pharma A/S

Prophylix Pharma A/S